Merck & Co (NY: MRK )

82.76 USD -0.17 (-0.20%)

Official Closing Price Updated: 5:43 PM EDT, Sep 28, 2020 Add to My Watchlist

Price and Volume

Volume	5,840,604
Open	83.20
Bid (Size)	82.51 (1)
Ask (Size)	82.89 (1)
Prev. Close	82.93
Today's Range	82.56 - 83.70
52wk Range	65.25 - 92.64
Shares Outstanding	2,690,303,898
Dividend Yield	2.32%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

NEXPLANON® Contraceptive Arm Implant Now Available for Use in Canada

September 24, 2020

Merck Joins Groundbreaking Gender and Diversity KPI Alliance

September 24, 2020

Performance

YTD	-10.08%	-10.08%
1 Month	-3.37%	-3.37%
3 Month	+8.72%	+8.72%
6 Month	+7.55%	+7.55%
1 Year	-1.69%	-1.69%

More News

Merck Animal Health Supports Rabies Elimination by 2030 on World Rabies Day

Today 6:45 EDT

Investors Are Scrambling To Get Ahead Of The Oncology Drug Market Boom; 1 Company Could Revolutionize The Industry

September 24, 2020

Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Reduced Risk of Death by 27% Versus Chemotherapy as First-Line Treatment for Locally Advanced or Metastatic Esophageal Cancer

September 21, 2020

First-Line Treatment With Merck’s KEYTRUDA® (pembrolizumab) Doubled Five-Year Survival Rate (31.9%) Versus Chemotherapy (16.3%) in Certain Patients With Metastatic Non-Small Cell Lung Cancer Whose Tum

September 21, 2020

There are four coronavirus vaccines in late-stage studies; here’s how they differ

September 25, 2020

LYNPARZA® (olaparib) Receives Positive Opinion from EU CHMP for Treatment of BRCA1/2 Metastatic Castration-Resistant Prostate Cancer (mCRPC)

September 21, 2020

Here's the Bigger Story About Moderna That You Might Be Missing

September 27, 2020

LYNPARZA® (olaparib) Recommended for Approval in EU by CHMP as First-Line Maintenance Treatment with Bevacizumab for HRD-Positive Advanced Ovarian Cancer

September 21, 2020

Notable Wednesday Option Activity: ZS, DRI, MRK

September 23, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.